BeiGene Market Cap

BeiGene has a market cap or net worth of $28.75 billion as of March 31, 2025. Its market cap has increased by 56.03% in one year.

Market Cap

28.75B

Enterprise Value

27.21B

Revenue

3.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

$19.78

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 858.74M to 28.75B, an increase of 3,248.35%. That is a compound annual growth rate of 46.75%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	28.75B	46.20%
Dec 31, 2024	19.67B	4.69%
Dec 29, 2023	18.79B	-17.76%
Dec 30, 2022	22.84B	-17.96%
Dec 31, 2021	27.84B	18.51%
Dec 31, 2020	23.49B	131.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.82B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	720.71M
Elite Pharmaceuticals	470.04M
Glass House Brands	371.89M
Northwest Biotherapeutics	318.00M
CytoDyn	288.56M

Market Cap Rankings